Victoria Kong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Victoria Kong has a total of 88 co-authors. Here are the top co-authors by number of shared publications:
Omar Allam
6 shared publicationsAndrew Salib
Division of Plastic Surgery, Department of Surgery, Yale School of Medicine , New Haven, CT
4 shared publicationsMartin Kauke-Navarro
4 shared publications- Andrew Salib
Department of Surgery, Division of Plastic and Reconstructive Surgery, Yale New Haven Hospital, Yale School of Medicine, New Haven, CT
3 shared publications Jake Moscarelli
From the Department of Surgery, Division of Plastic and Reconstructive Surgery, Yale New Haven Hospital, Yale School of Medicine ; New Haven, Connecticut
3 shared publications- Martin Kauke-Navarro
Division of Plastic Surgery, Department of Surgery, Yale School of Medicine, New Haven, USA
3 shared publications
Latest Publications
- Open Access
- 30 October 2026
- Published by Oxford University Press (OUP) in Aesthetic Surgery Journal Open Forum
Silent Saboteur: Hypertension is a Significant Risk Factor for Complications After Cosmetic Abdominoplasty
Background: Hypertension has a global prevalence of over 30% in the adults and is associated with adverse surgical outcomes. However, its specific impact on postoperative complications in cosmetic abdominoplasty remains underexplored. Objectives: To evaluate the association between medically treated hypertension and 30-day postoperative complications following elective cosmetic abdominoplasty. Methods: The ACS-NSQIP database (2008-2022) was retrospectively analyzed for adult patients undergoing elective cosmetic abdominoplasty. All patients were categorized into two groups: those medically treated for hypertension (MedHyp) and those without (NoMedHyp). Univariate analysis, multivariate logistic regression, and propensity score matching (PSM) evaluated 30-day postoperative outcomes. Results: Of 1,791 patients, 1,457 (81%) were NoMedHyp group (mean age: 43.9 ± 10.5 years; BMI: 28.2 ± 5.8 kg/m2) and 334 (19%) MedHyp (mean age: 52.5 ± 10.6 years; BMI: 31.1 ± 6.2 kg/m2; both p < 0.001). The overall complication rate was 6.0% (n = 107), with 4.8% (n = 70) in NoMedHyp and 11% (n = 37) in MedHyp (p < 0.001). Multivariate analysis showed hypertension was significantly associated with increased odds of overall (OR: 2.35, p < 0.001) and surgical complications (OR: 2.91, p < 0.001), including deep incisional infections (OR: 4.67, p = 0.04) and bleeding requiring transfusion (OR: 6.81, p < 0.001). After PSM (balancing age, BMI, and race), hypertension remained significantly associated with higher overall (OR: 3.08, p < 0.001) and surgical complications (OR: 3.44, p = 0.003), including bleeding requiring transfusion (OR: 9.22, p = 0.04). Conclusions: Hypertension is a significant risk factor for postoperative complications in cosmetic abdominoplasty, particularly for surgical complications and bleeding.
- 30 October 2026
- Published by Oxford University Press (OUP) in Aesthetic Surgery Journal Open Forum
Open AccessSilent Saboteur: Hypertension is a Significant Risk Factor for Complications After Cosmetic Abdominoplasty
Background: Hypertension has a global prevalence of over 30% in the adults and is associated with adverse surgical outcomes. However, its specific impact on postoperative complications in cosmetic abdominoplasty remains underexplored. Objectives: To evaluate the association between medically treated hypertension and 30-day postoperative complications following elective cosmetic abdominoplasty. Methods: The ACS-NSQIP database (2008-2022) was retrospectively analyzed for adult patients undergoing elective cosmetic abdominoplasty. All patients were categorized into two groups: those medically treated for hypertension (MedHyp) and those without (NoMedHyp). Univariate analysis, multivariate logistic regression, and propensity score matching (PSM) evaluated 30-day postoperative outcomes. Results: Of 1,791 patients, 1,457 (81%) were NoMedHyp group (mean age: 43.9 ± 10.5 years; BMI: 28.2 ± 5.8 kg/m2) and 334 (19%) MedHyp (mean age: 52.5 ± 10.6 years; BMI: 31.1 ± 6.2 kg/m2; both p < 0.001). The overall complication rate was 6.0% (n = 107), with 4.8% (n = 70) in NoMedHyp and 11% (n = 37) in MedHyp (p < 0.001). Multivariate analysis showed hypertension was significantly associated with increased odds of overall (OR: 2.35, p < 0.001) and surgical complications (OR: 2.91, p < 0.001), including deep incisional infections (OR: 4.67, p = 0.04) and bleeding requiring transfusion (OR: 6.81, p < 0.001). After PSM (balancing age, BMI, and race), hypertension remained significantly associated with higher overall (OR: 3.08, p < 0.001) and surgical complications (OR: 3.44, p = 0.003), including bleeding requiring transfusion (OR: 9.22, p = 0.04). Conclusions: Hypertension is a significant risk factor for postoperative complications in cosmetic abdominoplasty, particularly for surgical complications and bleeding.
- 12 October 2026
- Published by Elsevier in Journal of Plastic, Reconstructive & Aesthetic Surgery
- Vol. 123, 359-369
Quantitative analysis of tissue oxygenation trajectories in DIEP flaps using near infrared spectroscopy: A retrospective cohort study
- 12 October 2026
- Published by Elsevier in Journal of Plastic, Reconstructive & Aesthetic Surgery
- Vol. 123, 359-369
Quantitative analysis of tissue oxygenation trajectories in DIEP flaps using near infrared spectroscopy: A retrospective cohort study
- Open Access
- 30 September 2026
- Published by Elsevier in Journal of Shoulder and Elbow Arthroplasty
- Vol. 10 (4)
Severe obesity as an independent risk factor for post-operative dislocation following reverse total shoulder arthroplasty: a PearlDiver database analysis
- 30 September 2026
- Published by Elsevier in Journal of Shoulder and Elbow Arthroplasty
- Vol. 10 (4)
Open AccessSevere obesity as an independent risk factor for post-operative dislocation following reverse total shoulder arthroplasty: a PearlDiver database analysis
- Open Access
- 19 August 2026
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 25 (8)
3D Stereophotogrammetry Analysis and Psychosocial Outcomes of Injectable Fillers in Gender‐Affirming Facial Contouring: A Prospective Analysis
Background: Gender‐affirming facial procedures alleviate dysphoria, yet prospective data on nonsurgical interventions remain scarce. Objective data on anatomical and psychosocial outcomes following injectable fillers in transgender populations are poorly defined. Aims: To quantitatively evaluate soft‐tissue changes and psychosocial outcomes following gender‐affirming facial contouring with hyaluronic acid (HA) fillers. Patients/Methods: In this prospective, single‐center study, 50 transgender patients (25 trans women and 25 trans men) underwent individualized HA filler treatments. Three‐dimensional (3D) stereophotogrammetry was performed using a VECTRA (Canfield Scientific, Parsippany, NJ, USA) to assess facial soft‐tissue changes at baseline and 30 days post‐treatment. Linear distances were measured on 3D facial images using the VECTRA Analysis Module software with integrated digital caliper tools. Psychosocial outcomes were measured using validated Likert‐type measures of satisfaction and gender identification, including the Global Aesthetic Improvement Scale (GAIS). Results: Mean injected volume was 9.8 ± 3.5 mL and was well tolerated, with no serious adverse events. Satisfaction and gender identification scores improved significantly (Δ + 1.53 and + 1.71, respectively; both p < 0.001). The 3D analysis demonstrated significant, directionally gender‐congruent changes. Trans women showed increases in bizygomatic width (+ 3.75 mm) and labial height (+ 1.77 mm), along with a reduction in perceived chin width (−12.94 mm). Trans men exhibited increases in bigonial width (+ 5.04 mm) and chin width (+ 4.53 mm) (all p < 0.001). Despite millimeter‐scale changes, these modifications were associated with substantial psychosocial improvement. Conclusions: This prospective study demonstrated measurable, gender‐congruent changes in facial morphology following injectable HA filler treatment, accompanied by improvements in patient‐reported satisfaction and gender identification. Despite similar injected volumes, anatomical effects differed between groups, reflecting strategic three‐dimensional redistribution of soft tissue rather than volume alone. These findings support nonsurgical facial contouring as an effective approach for gender affirmation.
- 19 August 2026
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 25 (8)
Open Access3D Stereophotogrammetry Analysis and Psychosocial Outcomes of Injectable Fillers in Gender‐Affirming Facial Contouring: A Prospective Analysis
Background: Gender‐affirming facial procedures alleviate dysphoria, yet prospective data on nonsurgical interventions remain scarce. Objective data on anatomical and psychosocial outcomes following injectable fillers in transgender populations are poorly defined. Aims: To quantitatively evaluate soft‐tissue changes and psychosocial outcomes following gender‐affirming facial contouring with hyaluronic acid (HA) fillers. Patients/Methods: In this prospective, single‐center study, 50 transgender patients (25 trans women and 25 trans men) underwent individualized HA filler treatments. Three‐dimensional (3D) stereophotogrammetry was performed using a VECTRA (Canfield Scientific, Parsippany, NJ, USA) to assess facial soft‐tissue changes at baseline and 30 days post‐treatment. Linear distances were measured on 3D facial images using the VECTRA Analysis Module software with integrated digital caliper tools. Psychosocial outcomes were measured using validated Likert‐type measures of satisfaction and gender identification, including the Global Aesthetic Improvement Scale (GAIS). Results: Mean injected volume was 9.8 ± 3.5 mL and was well tolerated, with no serious adverse events. Satisfaction and gender identification scores improved significantly (Δ + 1.53 and + 1.71, respectively; both p < 0.001). The 3D analysis demonstrated significant, directionally gender‐congruent changes. Trans women showed increases in bizygomatic width (+ 3.75 mm) and labial height (+ 1.77 mm), along with a reduction in perceived chin width (−12.94 mm). Trans men exhibited increases in bigonial width (+ 5.04 mm) and chin width (+ 4.53 mm) (all p < 0.001). Despite millimeter‐scale changes, these modifications were associated with substantial psychosocial improvement. Conclusions: This prospective study demonstrated measurable, gender‐congruent changes in facial morphology following injectable HA filler treatment, accompanied by improvements in patient‐reported satisfaction and gender identification. Despite similar injected volumes, anatomical effects differed between groups, reflecting strategic three‐dimensional redistribution of soft tissue rather than volume alone. These findings support nonsurgical facial contouring as an effective approach for gender affirmation.
- Open Access
- 19 August 2026
- Published by Elsevier in JPRAS Open
- Vol. 52, 213-225
Material type versus defect size in adult cranioplasty: a multi-institutional analysis of 30-day outcomes and risk prediction modeling
- 19 August 2026
- Published by Elsevier in JPRAS Open
- Vol. 52, 213-225
Open AccessMaterial type versus defect size in adult cranioplasty: a multi-institutional analysis of 30-day outcomes and risk prediction modeling
- Open Access
- 1 July 2026
- Published by Oxford University Press (OUP) in Aesthetic Surgery Journal Open Forum
- Vol. 8, ojag135
Three-Dimensional Morphometric Trajectories Following Lip Lift With or Without Fat Grafting in Facial Feminization Patients
Background: Subnasal lip lifts address perioral aging, but long-term quantitative data on postoperative changes and permanence remain limited. Objectives: To provide the first three-dimensional (3D) evaluation of morphometric changes after subnasal lip lift ± autologous fat grafting over time. Methods: A retrospective cohort (2022–2025) of facial feminization patients undergoing subnasal lip lift ± fat grafting was analyzed. Standardized VECTRA 3D imaging measured philtral height, vermilion height and width, nasal base width, columella-labial angle, surface area, and lip volume preoperatively and at serial postoperative intervals. Early changes (3 months) were compared using t-tests, and longitudinal trajectories with linear mixed-effects models. Results: 40 patients were included (lip lift alone, n=10; lip lift + fat grafting, n=30). Both cohorts showed significant early philtral shortening (–2.92 ± 1.53 mm, p= 0.013 vs –5.95 ± 1.77 mm, p<0.001) and increased upper vermilion surface area (1.40 ± 0.86 cm2, p=0.022 vs 1.42 ± 1.23 cm2, p=0.022). Fat grafting produced greater early volumetric augmentation (1.18 ± 0.86 cc vs 0.53 ± 0.25 cc), though between-group differences did not reach statistical significance. Mixed-effects modeling showed significant divergence in permanence. Philtral shortening showed 43% retention by 24 months (p=0.003), whereas volumetric and surface area gains approached zero by 22 and 24 months, respectively. Conclusions: There is measurable philtral shortening after subnasal lip lift. However, partial re-lengthening occurs over time. Additionally, early gains in vermilion display and lip volume decrease substantially by two years. Fat grafting enhances early augmentation but shows limited long-term retention.
- 1 July 2026
- Published by Oxford University Press (OUP) in Aesthetic Surgery Journal Open Forum
- Vol. 8, ojag135
Open AccessThree-Dimensional Morphometric Trajectories Following Lip Lift With or Without Fat Grafting in Facial Feminization Patients
Background: Subnasal lip lifts address perioral aging, but long-term quantitative data on postoperative changes and permanence remain limited. Objectives: To provide the first three-dimensional (3D) evaluation of morphometric changes after subnasal lip lift ± autologous fat grafting over time. Methods: A retrospective cohort (2022–2025) of facial feminization patients undergoing subnasal lip lift ± fat grafting was analyzed. Standardized VECTRA 3D imaging measured philtral height, vermilion height and width, nasal base width, columella-labial angle, surface area, and lip volume preoperatively and at serial postoperative intervals. Early changes (3 months) were compared using t-tests, and longitudinal trajectories with linear mixed-effects models. Results: 40 patients were included (lip lift alone, n=10; lip lift + fat grafting, n=30). Both cohorts showed significant early philtral shortening (–2.92 ± 1.53 mm, p= 0.013 vs –5.95 ± 1.77 mm, p<0.001) and increased upper vermilion surface area (1.40 ± 0.86 cm2, p=0.022 vs 1.42 ± 1.23 cm2, p=0.022). Fat grafting produced greater early volumetric augmentation (1.18 ± 0.86 cc vs 0.53 ± 0.25 cc), though between-group differences did not reach statistical significance. Mixed-effects modeling showed significant divergence in permanence. Philtral shortening showed 43% retention by 24 months (p=0.003), whereas volumetric and surface area gains approached zero by 22 and 24 months, respectively. Conclusions: There is measurable philtral shortening after subnasal lip lift. However, partial re-lengthening occurs over time. Additionally, early gains in vermilion display and lip volume decrease substantially by two years. Fat grafting enhances early augmentation but shows limited long-term retention.
- Open Access
- 23 June 2026
- Published by Elsevier in SSRN Electronic Journal
Finding the Sweet Spot? Differential Diabetes Risks in Autologous Breast Reconstruction
BackgroundAutologous breast reconstruction (ABR) offers superior quality of life compared with implant-based reconstruction or mastectomy alone but carries substantial perioperative risk. Diabetes mellitus is a known predictor of postoperative morbidity but is often treated as a binary variable, obscuring differences between patients on oral antihyperglycemic agents (DM-ORAL) and insulin (DM-INS).MethodsUsing the National Surgical Quality Improvement Program, we identified female breast cancer patients undergoing immediate ABR (2008–2021). Diabetes status was categorized as non-diabetic, DM-ORAL, or DM-INS. Primary outcomes were 30-day adverse events, reoperation, unplanned readmission, and surgical and medical complications. Groups were compared and multivariable regression used to adjust for confounders.ResultsOf 8,121 patients, 559 (6.9%) had diabetes, including 457 (81.8%) DM-ORAL and 102 (18.2%) DM-INS. Diabetes prevalence increased over time with a 0.3 percentage-point annual rise (R2=0.58; p=0.003), driven mainly by DM-ORAL (R2=0.52; p=0.005), while DM-INS showed a non-significant trend (R2=0.28; p=0.07). Compared with non-diabetic patients, diabetics had higher overall complication rates (34.7% vs. 24.1%), including medical (6.4% vs. 2.8%) and surgical complications (23.6% vs. 15.2%) (all p<0.0001). Within diabetics, DM-INS demonstrated higher morbidity, including unplanned readmission (14.7% vs. 6.3%, p=0.008) and superficial infection (10.8% vs. 5.3%, p=0.04) compared to DM-ORAL. On multivariable analysis, diabetes independently predicted complications (OR 1.4), with higher risk in DM-INS (OR 1.9) than DM-ORAL (OR 1.3); DM-INS more than doubled surgical complication risk (OR 2.5).ConclusionDiabetes is a significant but heterogeneous risk factor in ABR, with insulin-treated patients at particularly elevated perioperative risk, supporting treatment-specific risk stratification.
- 23 June 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessFinding the Sweet Spot? Differential Diabetes Risks in Autologous Breast Reconstruction
BackgroundAutologous breast reconstruction (ABR) offers superior quality of life compared with implant-based reconstruction or mastectomy alone but carries substantial perioperative risk. Diabetes mellitus is a known predictor of postoperative morbidity but is often treated as a binary variable, obscuring differences between patients on oral antihyperglycemic agents (DM-ORAL) and insulin (DM-INS).MethodsUsing the National Surgical Quality Improvement Program, we identified female breast cancer patients undergoing immediate ABR (2008–2021). Diabetes status was categorized as non-diabetic, DM-ORAL, or DM-INS. Primary outcomes were 30-day adverse events, reoperation, unplanned readmission, and surgical and medical complications. Groups were compared and multivariable regression used to adjust for confounders.ResultsOf 8,121 patients, 559 (6.9%) had diabetes, including 457 (81.8%) DM-ORAL and 102 (18.2%) DM-INS. Diabetes prevalence increased over time with a 0.3 percentage-point annual rise (R2=0.58; p=0.003), driven mainly by DM-ORAL (R2=0.52; p=0.005), while DM-INS showed a non-significant trend (R2=0.28; p=0.07). Compared with non-diabetic patients, diabetics had higher overall complication rates (34.7% vs. 24.1%), including medical (6.4% vs. 2.8%) and surgical complications (23.6% vs. 15.2%) (all p<0.0001). Within diabetics, DM-INS demonstrated higher morbidity, including unplanned readmission (14.7% vs. 6.3%, p=0.008) and superficial infection (10.8% vs. 5.3%, p=0.04) compared to DM-ORAL. On multivariable analysis, diabetes independently predicted complications (OR 1.4), with higher risk in DM-INS (OR 1.9) than DM-ORAL (OR 1.3); DM-INS more than doubled surgical complication risk (OR 2.5).ConclusionDiabetes is a significant but heterogeneous risk factor in ABR, with insulin-treated patients at particularly elevated perioperative risk, supporting treatment-specific risk stratification.
- 27 May 2026
- Published by Elsevier in Journal of Plastic, Reconstructive & Aesthetic Surgery
- Vol. 118, 361-372
Rising costs despite declining resource utilization: Widening disparities in adolescent reduction mammaplasty
- 27 May 2026
- Published by Elsevier in Journal of Plastic, Reconstructive & Aesthetic Surgery
- Vol. 118, 361-372
Rising costs despite declining resource utilization: Widening disparities in adolescent reduction mammaplasty
- 8 May 2026
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 61 (8) , 163192
Mastectomy for adolescent gynecomastia associated with lower risk of incident psychiatric diagnosis
- 8 May 2026
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 61 (8) , 163192
Mastectomy for adolescent gynecomastia associated with lower risk of incident psychiatric diagnosis
- 7 May 2026
- Published by Elsevier in Journal of Oral and Maxillofacial Surgery
- Vol. 84 (10) , 1597-1603
Predictors of New-Onset Anxiety or Depression Following Open Reduction and Internal Fixation of Mandible Fractures.
- 7 May 2026
- Published by Elsevier in Journal of Oral and Maxillofacial Surgery
- Vol. 84 (10) , 1597-1603
Predictors of New-Onset Anxiety or Depression Following Open Reduction and Internal Fixation of Mandible Fractures.